ECDC report on Creutzfeldt–Jakob disease in the EU and Norway
The new report on the prevention of Creutzfeldt–Jakob (vCJD) disease transmission in medical settings provides a comprehensive analysis of the epidemiological situation in EU Member States and Norway. It represents a useful tool for Member States public health experts and policymakers.
ECDC today releases a technical report on the prevention of Creutzfeldt–Jakob (vCJD) disease transmission in medical settings in EU Member States and Norway.
Since its identification in 1996 in the UK, outbreaks of the neurological disease classified as a Transmissible Spongiform Encephalopathy (TSE) occurred in several Member States. Both the European Union and individual countries have implemented special public health measures and strengthened research efforts in the field of human and animal TSEs.
The report provides a review of national documents aimed at controlling the transmission of Creutzfeldt–Jakob disease transmission in medical settings. By thoroughly analysing the epidemiological situation and recent research, it represents a useful tool for Member States in order to identify their specific needs.
European Antibiotic Awareness Day: new website, new online resources
The new European Antibiotic Awareness Day (EAAD) website is a more dynamic and easy-to-access hub for resources to raise awareness about prudent use of antibiotics and about antibiotic resistance.Read more
Measles in the EU/EEA: current outbreaks, latest data and trends – October 2017
Measles outbreaks continue to occur in a number of EU/EEA countries, and there is a risk of spread and sustained transmission in areas with susceptible populations.Read more
Epidemiological update: multi-country outbreak of Salmonella Enteritidis with MLVA profile 2-9-7-3-2 or 2-9-6-3-2 infections
Since the previous ECDC epidemiological update was published on 30 June 2017, seven EU/EEA countries (Belgium, France, Luxembourg, the Netherlands, Norway, Sweden and the United Kingdom) have reported 96 confirmed and 34 probable new cases associated with the multi-country outbreak of Salmonella Enteritidis with MLVA profiles 2-9-7-3-2 or 2-9-6-3-2 ongoing in the EU/EEA.Read more